Introduction
According to the research, it was predicted that cancer incidence in India varied from 44-122 per 100,000 population in males and 52-128 per 100,000 population in females [1] . It was estimated that, at present, nearly one million new cancer cases were being detected annually in the country [1] . For patients and their family, a diagnosis of cancer brings challenges to many aspects of daily life, with a major concern of being maintaining the highest quality of life possible during and after the experience [1] . Because of the aggressive cancer symptoms, patients with cancer and their families might face ongoing and challenging medical decisions that progressively and rapidly erode cognition [2] . Quality of Life (QOL) is a descriptive term that referred to people′s emotional, social, and physical well-being as well as their ability to function in ordinary tasks of living [1] . The informed consent process consisted of 3 principles, viz., (1) Knowledge (the research proposal should state benefits and risks along with the alternative treatments and the outcome measures; (2) Voluntariness of the participant in which the pressure from the family is acceptable; (3) Competence where patient should understand the information disclosed [3] . Assessing a patient's medical decision-making capacity is a part of every medical research study [3] . The process is generally spontaneous and straightforward: during the performance of routine inpatient and outpatient visits, the researcher should confirm the ability of the cancer patients to understand their medical condition and options for care [3] . To perform this analysis of ability of a cancer patient to consent, a directed clinical interview is the best available option [3] . The clinical interview might consist of questions pertaining to case history from the care-givers or laboratory findings [3] . For some patients, however, the assessment may not be straightforward [3] . Currently, if a person failed to have the capacity to consent to treatment or research, substitute decision makers were employed (e.g., legal representatives or family members) [4] . Thus, a judgement by health care professionals that a person was not competent to provide informed consent might have a profound effect on the autonomy, or free will, of an individual [4] . Contemporary ideas on informed consent stem, in part, from the Nuremberg Code following the Second World War [4] . The code specified that consent to research should be voluntary and that participants should have free choice, adequate understanding, and the capacity to give consent [4] . 
Aims
The main objectives of the present study were:
i. To determine and analyze the ability of cancer patient to consent during inpatient chemotherapy treatment or outpatient radiotherapy treatment. ii. To evaluate the percentage of cancer patients enrolled in the study that required assistance either from the interviewer or from the care-givers in filling up the QOL questionnaire form during the chemotherapy or radiotherapy sessions.
Patients and methods
During the conduct of the proposed study Ethical Procedures were respected. , 2015) for the research study protocol from IRB and Ethical committee from Dr. B.L. Kapur Memorial Hospital, New Delhi, patients and their caregivers were approached in the inpatient as well as, outpatient clinic, where the purpose of the study was explained and they were invited to participate. Patients who agreed to participate were asked to sign an Informed Consent Form followed by the implementation of the instrument in the form of questionnaires. [6] , and Zung Self-rating Depression Scale (ZSDS) that consisted of 20 questions on a four-point likert scale [7] 4. Eligible patients were identified through an institutional database or by referring physicians and were approached at their simulation appointment. After giving written informed consent from . the patient or their caregivers, participants completed the assessment that included the self-report measures. 5. Patients who agreed to participate were asked to sign an informed consent and then the instruments in the form of questionnaire were applied. Subjective areas were covered using case histories. 6. Special care of the potential risks due to emotional distress was taken care of so that their dignity was not harmed. 7. A total of 5-6 interviews were performed per week, in the time and days most suitable for the clinic in the months of December 2015 to April 2016. 8. Each interview lasted approximately 25-60 minutes and all patients were thanked for their participation, valuable time and information in the end.
Results (a) Data collection
Treatment-related symptoms were assessed using a series of interviews through standard questionnaires of WHOQOL-Bref, the core questionnaire, followed by Zung Self-rating Anxiety Scale (ZSAS) and Zung Self Rating Depression Scale (ZSDS) Questionnaires. The questionnaire was provided in a language that the patient could understand (English / Hindi) followed by interview of the patient who was either undergoing chemotherapy or radiotherapy treatment sessions The database and statistical analysis was performed using SPSS v.17 software. Measures such as mean, standard deviation, minimum and maximum range were developed from the continuous data. Relative frequency was calculated for discrete data. A p-value < 0.05 was considered as statistical significant. QOL domain scores for chemotherapy sessions (n = 30) In the chemotherapy group, the physical domain was the most affected domain, followed by social domain, psychological and environmental domain. In the radiotherapy group, the physical domain was the most affected domain, followed by social domain, psychological and environmental domain.
Socio-demographic characteristics of the patients

Clinical characteristics of the patients
QOL domain scores for Radiotherapy sessions (n = 30)
Measuring ability of a cancer patient to consent in chemotherapy as well as, radiotherapy group while participating in QOL assessment 13 Table 5 . Measuring ability of a cancer patient to consent in chemotherapy as well as, radiotherapy group. It can be observed from table no. 3 and 4that in the chemotherapy group whose anxiety level (Mean= 66.62) and depression level (Mean= 58.66) as measured by ZSAS and ZSDS, respectively, patients were able to consent themselves 20(66.6%), assisted by relatives/caregivers 2(6.7%), and assisted by the researcher 8 (26.7%) in order to, particpate in the research study entitled to "QOL of cancer patients during inpatient chemotherapy or outpatient radiotherapy".
Process of
On the other hand, in the radiotherapy group whose anxiety level (Mean= 53.95) and depression level (Mean= 52.12) as measured by ZSAS and ZSDS, respectively, patients were able to consent themselves 23(76.7%), assisted by relatives/caregivers 3(10.0%), and assisted by the researcher 4(13.3%) in order to, particpate in the research study entitled to "QOL of cancer patients during inpatient chemotherapy or outpatient radiotherapy".
Discussion
The present study aimed at how the cancer patient undergoing either chemotherapy or radiotherapy sessions consented their ability to participate in the study entitled to "QOL of cancer patients during inpatient chemotherapy or outpatient radiotherapy treatment". From the data retrieved it was observed that though cancer patients were suffering from the phase of anxiety and depression during the course of their treatment, yet maximum of the patients in both the treatment groups were able to consent their participation in the present research survey. All the studies published so far have included the standardized tools for measuring Medical competence to consent. However, in the present study, there was no such tool was utilized instead a general part is presented while assessing for the QOL of cancer patients during the chemotherapy or radiotherapy sessions.
Conclusion
Therefore, it could be concluded that Medical capacity to consent for participating in research study is an important aspect in cancer population as well. During the chemotherapy sessions or radiotherapy sessions, the cognitive ability gets affected. So, while conducting research survey it is important that the care-giver along with the researcher should be present with the cancer patient (subject) at the time of interview (research study).
Future directions
a. Larger sample size for the evaluation of the research study could be used. b. Standardized assessment tools for medical capacity to consent in cancer patients could be used in order to, understand and analyze QOL of cancer patients during chemotherapy or radiotherapy treatment.
